Status:
COMPLETED
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Growth Hormone Deficiency
Septo-Optic Dysplasia
Eligibility:
All Genders
Up to 5 years
Phase:
PHASE4
Brief Summary
Hypotheses: 1. The prevalence of endocrinopathies, and growth hormone (GH) deficiency in particular, among young children diagnosed with optic nerve hypoplasia (ONH) is higher than is commonly though...
Detailed Description
Subjects for this study will be recruited from active and newly enrolled subjects in our larger ONH study. The study duration is three years and we anticipate 38 subjects will enroll. Subjects will be...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- New subjects diagnosed with ONH less than or equal to 2 years of age and subjects actively enrolled (in currently approved prospective ONH study) will be eligible for enrollment.
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00140413
Start Date
December 1 2004
End Date
February 1 2014
Last Update
April 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital Los Angeles
Los Angeles, California, United States, 90027